Lorena Rentero-Redondo
El Palmar, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Utility of tolerance assays for real-time management of infliximab infusion reactions.
Journal: Revista espanola de enfermedades digestivas
Published: January 22, 2026
Immunogenicity phenotypes and reversal of pharmacokinetic impact in anti-TNF-treated immune-mediated diseases: a real-world study.
Journal: International journal of clinical pharmacy
Published: August 10, 2025
STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient.
Journal: British journal of clinical pharmacology
Published: July 16, 2025
Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes.
Journal: Gastroenterologia y hepatologia
Published: March 04, 2025
External Evaluation of Population Pharmacokinetic Models of Ustekinumab in Patients with Inflammatory Bowel Disease.
Journal: Therapeutic drug monitoring
Published: January 23, 2025
Managing refractory cytomegalovirus in an immunosuppressed patient with sarcoidosis: a case report on maribavir therapy.
Journal: European journal of hospital pharmacy : science and practice
Published: December 10, 2024
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease.
Journal: Revista espanola de enfermedades digestivas
Published: December 04, 2024
Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients.
Journal: Gastroenterologia y hepatologia
Published: August 05, 2024
Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab.
Journal: Therapeutic drug monitoring
Published: May 22, 2024
Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease.
Journal: European journal of hospital pharmacy : science and practice
Published: April 19, 2024
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study.
Journal: Gastroenterologia y hepatologia
Published: May 18, 2023
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach.
Journal: Revista espanola de enfermedades digestivas
Published: December 23, 2022
Last Updated: 09/26/2026